These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 23236213)

  • 41. Amyloid Beta-Weighted Cortical Thickness: A New Imaging Biomarker in Alzheimer's Disease.
    Kim CM; Hwang J; Lee JM; Roh JH; Lee JH; Koh JY;
    Curr Alzheimer Res; 2015; 12(6):563-71. PubMed ID: 26027813
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inflammation, Amyloid, and Atrophy in The Aging Brain: Relationships with Longitudinal Changes in Cognition.
    Sala-Llonch R; Idland AV; Borza T; Watne LO; Wyller TB; Brækhus A; Zetterberg H; Blennow K; Walhovd KB; Fjell AM
    J Alzheimers Dis; 2017; 58(3):829-840. PubMed ID: 28505968
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals.
    Dickerson BC; Bakkour A; Salat DH; Feczko E; Pacheco J; Greve DN; Grodstein F; Wright CI; Blacker D; Rosas HD; Sperling RA; Atri A; Growdon JH; Hyman BT; Morris JC; Fischl B; Buckner RL
    Cereb Cortex; 2009 Mar; 19(3):497-510. PubMed ID: 18632739
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging.
    Zhao Y; Raichle ME; Wen J; Benzinger TL; Fagan AM; Hassenstab J; Vlassenko AG; Luo J; Cairns NJ; Christensen JJ; Morris JC; Yablonskiy DA
    Neuroimage; 2017 Mar; 148():296-304. PubMed ID: 27989773
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
    J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Variations in cortical thickness with dementia severity in Alzheimer's disease.
    Im K; Lee JM; Seo SW; Yoon U; Kim ST; Kim YH; Kim SI; Na DL
    Neurosci Lett; 2008 May; 436(2):227-31. PubMed ID: 18400396
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum.
    Liu Y; Tan L; Wang HF; Liu Y; Hao XK; Tan CC; Jiang T; Liu B; Zhang DQ; Yu JT;
    Mol Neurobiol; 2016 Sep; 53(7):4539-47. PubMed ID: 26298664
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cerebrospinal fluid abnormalities and rate of decline in everyday function across the dementia spectrum: normal aging, mild cognitive impairment, and Alzheimer disease.
    Okonkwo OC; Alosco ML; Griffith HR; Mielke MM; Shaw LM; Trojanowski JQ; Tremont G;
    Arch Neurol; 2010 Jun; 67(6):688-96. PubMed ID: 20558388
    [TBL] [Abstract][Full Text] [Related]  

  • 49. One-year brain atrophy evident in healthy aging.
    Fjell AM; Walhovd KB; Fennema-Notestine C; McEvoy LK; Hagler DJ; Holland D; Brewer JB; Dale AM
    J Neurosci; 2009 Dec; 29(48):15223-31. PubMed ID: 19955375
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential effects of aging and Alzheimer's disease on medial temporal lobe cortical thickness and surface area.
    Dickerson BC; Feczko E; Augustinack JC; Pacheco J; Morris JC; Fischl B; Buckner RL
    Neurobiol Aging; 2009 Mar; 30(3):432-40. PubMed ID: 17869384
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
    Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
    J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Brain volume decline in aging: evidence for a relation between socioeconomic status, preclinical Alzheimer disease, and reserve.
    Fotenos AF; Mintun MA; Snyder AZ; Morris JC; Buckner RL
    Arch Neurol; 2008 Jan; 65(1):113-20. PubMed ID: 18195148
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Amyloid-β-related and unrelated cortical thinning in dementia with Lewy bodies.
    Lee YG; Jeon S; Yoo HS; Chung SJ; Lee SK; Lee PH; Sohn YH; Yun M; Evans AC; Ye BS
    Neurobiol Aging; 2018 Dec; 72():32-39. PubMed ID: 30205358
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia.
    Du AT; Schuff N; Kramer JH; Rosen HJ; Gorno-Tempini ML; Rankin K; Miller BL; Weiner MW
    Brain; 2007 Apr; 130(Pt 4):1159-66. PubMed ID: 17353226
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease.
    van Rossum IA; Visser PJ; Knol DL; van der Flier WM; Teunissen CE; Barkhof F; Blankenstein MA; Scheltens P
    J Alzheimers Dis; 2012; 29(2):319-27. PubMed ID: 22233766
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cerebral changes and disrupted gray matter cortical networks in asymptomatic older adults at risk for Alzheimer's disease.
    Cantero JL; Atienza M; Sanchez-Juan P; Rodriguez-Rodriguez E; Vazquez-Higuera JL; Pozueta A; Gonzalez-Suarez A; Vilaplana E; Pegueroles J; Montal V; Blesa R; Alcolea D; Lleo A; Fortea J
    Neurobiol Aging; 2018 Apr; 64():58-67. PubMed ID: 29331877
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of amyloid pathology and neurodegeneration on cognitive change in cognitively normal adults.
    Bilgel M; An Y; Helphrey J; Elkins W; Gomez G; Wong DF; Davatzikos C; Ferrucci L; Resnick SM
    Brain; 2018 Aug; 141(8):2475-2485. PubMed ID: 29901697
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alzheimer's disease and frontotemporal dementia exhibit distinct atrophy-behavior correlates: a computer-assisted imaging study.
    Gee J; Ding L; Xie Z; Lin M; DeVita C; Grossman M
    Acad Radiol; 2003 Dec; 10(12):1392-401. PubMed ID: 14697007
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies.
    van Steenoven I; van der Flier WM; Scheltens P; Teunissen CE; Lemstra AW
    Alzheimers Res Ther; 2019 Oct; 11(1):83. PubMed ID: 31601267
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CSF biomarker pathology correlates with a medial temporo-parietal network affected by very mild to moderate Alzheimer's disease but not a fronto-striatal network affected by healthy aging.
    Fjell AM; Amlien IK; Westlye LT; Stenset V; Fladby T; Skinningsrud A; Eilsertsen DE; Bjørnerud A; Walhovd KB
    Neuroimage; 2010 Jan; 49(2):1820-30. PubMed ID: 19800012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.